Celltrion's COVID-19 Treatment Enters Review Process

  • Arirang News

    December 30, 2020 08:32

    An antibody treatment for COVID-19 made by Korean bio-pharmaceutical company Celltrion has entered the review process.

    The company applied for the review on Tuesday.

    The Ministry of Food and Drug Safety said it will decide whether to grant approval within 40 days.

    Celltrion is the third company in the world to apply for approval for an experimental COVID-19 treatment, after Eli Lilly and Regeneron.

    The company plans to apply for emergency-use approval in the U.S. and Europe next month.

    • Copyright © Chosunilbo & Chosun.com
    Previous Next
    All Headlines Back to Top